Fluctuating eye pressure associated with visual field deterioration in glaucoma patientsAugust 14, 2007Fluctuations in eye pressure may be associated with a decreasing peripheral field of vision in patients with glaucoma, even if their eye pressure remains low overall, according to a report in the August issue of Archives of Ophthalmology, one of the JAMA/Archives journals. "Prevention of further visual field deterioration is a goal of glaucoma therapy," the authors write as background information in the article. "Previous studies reported that lowering intraocular pressure (IOP) slowed the advancement of visual field damage in patients with glaucoma. However, even if the IOP can be substantially lowered, reduction of mean [average] and peak IOP does not always prevent progressive visual field deterioration." Samin Hong, M.D., and colleagues at the Yonsei University College of Medicine, Seoul, Korea, studied 408 eyes of patients (average age 66.5 years) who had undergone a triple procedure to treat glaucoma: phacoemulsification, that involves dissolving and removing the lens; posterior chamber intraocular lens implantation; and trabeculectomy, also known as filtration surgery. All patients had a low IOP after surgery (below 18 milligrams of mercury). Measurements of IOP and visual field were taken for an average of 9.2 years following surgery. Based on the standard deviation (difference from the average) in IOP, the eyes were split into two groups, one with greater fluctuation and one with less.
Throughout the follow-up period, the two groups had the same average IOP, and their visual fields were the same after three months. However, after the last follow-up examination-13 years later-the visual field was significantly worse in the group with greater fluctuation in IOP. The number of patients with progressive visual field loss was significantly larger in the group with more fluctuation. "Our results suggest that glaucomatous visual field damage cannot be stabilized by only lowering the postoperative IOP but also requires reducing the long-term fluctuation of the post-operative IOP," the authors conclude. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Glaucoma Current Events and Glaucoma News Articles Melatonin may save eyesight in inflammatory disease Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology. Eye conditions linked with obstructive sleep apnea If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus. In the November issue of Mayo Clinic Proceedings, Mayo Clinic researchers outline several interesting associations between sleep disorders and eye disease. Vision loss more common in people with diabetes Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals. Medication slows progression of myopia in children Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus). Glaucoma procedure now available at Mayo Clinic aims to prevent further eye damage For the first time in Florida, patients with glaucoma have a new treatment option known as the Trabectome. Case Western Reserve and Penn State investigators inhibit corneal inflammation Researchers from the Case Western Reserve University School of Medicine and Penn State Hershey College of Medicine identified a novel therapeutic that reduces sterile inflammation within the cornea. Glaucoma report points to increased costs A new Centre for Eye Research Australia/ Access Economics report shows the cost of glaucoma will more than double in the next two decades. 'Fluorescent' cells give early warning for eye disease Scientists at the University of Michigan have shown that their new metabolic imaging instrument can accurately detect eye disease at a very early stage. Role identified for glaucoma gene and related signaling pathway Researchers have found that a gene and a related signaling pathway play a role in the development of glaucoma, which is a common cause of visual impairment and blindness worldwide. Cost of glaucoma medications may impact treatment In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total. More Glaucoma Current Events and Glaucoma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||